Open access · CC-BY
via OpenAlex
Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease
Veselin Grozdanov, Luc Bousset, Meike Hoffmeister, Corinna Bliederhaeuser, Christoph Andreas Meier, Karine Madiona, Laura Pieri, Martin Kiechle, Pamela J. McLean, Jan Kassubek, Christian Behrends, Albert Christian Ludolph, Jochen Hans Weishaupt, Ronald Melki, Karin M. Danzer
Annals of Neurology · 2019 · ▲ 160 citations
Abstract
OBJECTIVE: Excessive inflammation in the central nervous system (CNS) and the periphery can result in neurodegeneration and parkinsonism. Recent evidence suggests that immune responses in Parkinson disease patients are dysregulated, leading to an increased inflammatory reaction to unspecific triggers. Although α-synuclein pathology is the hallmark of Parkinson disease, it has not been investigated whether pathologic α-synuclein is a specific trigger for excessive inflammatory responses in Parkinson disease. METHODS: We investigated the immune response of primary human monocytes and a microglial cell line to pathologic forms of α-synuclein by assessing cytokine release upon exposure. RESULTS: We show that pathologic α-synuclein (mutations, aggregation) results in a robust inflammatory activation of human monocytes and microglial BV2 cells. The activation is conformation- dependent, with increasing fibrillation and early onset mutations having the strongest effect on immune activation. We also found that activation of immune cells by extracellular α-synuclein is potentiated by extracellular vesicles, possibly by facilitating the uptake of α-synuclein. Blood extracellular vesicles from Parkinson disease patients induce a stronger activation of monocytes than blood extracellular vesicles from healthy controls. Most importantly, monocytes from Parkinson disease patients are dysregulated and hyperactive in response to stimulation with pathologic α-synuclein. Furthermore, we demonstrate that α-synuclein pathology in the CNS is sufficient to induce the monocyte dysregulation in the periphery of a mouse model. INTERPRETATION: Taken together, our data suggest that α-synuclein pathology and dysregulation of monocytes in Parkinson disease can act together to induce excessive inflammatory responses to α-synuclein. ANN NEUROL 2019;86:593-606.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/ana.25557
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Grozdanov, V., Bousset, L., Hoffmeister, M., Bliederhaeuser, C., Meier, C.A., Madiona, K., Pieri, L., Kiechle, M., McLean, P.J., Kassubek, J., Behrends, C., Ludolph, A.C., Weishaupt, J.H., Melki, R., & Danzer, K.M. (2019). Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease. <em>Annals of Neurology</em>. https://doi.org/10.1002/ana.25557
Vancouver
Grozdanov V, Bousset L, Hoffmeister M, Bliederhaeuser C, Meier CA, Madiona K, et al. Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease. Annals of Neurology. 2019. doi:10.1002/ana.25557.
BibTeX
@article{veselin2019Increa,
title = {Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease},
author = {Veselin Grozdanov and Luc Bousset and Meike Hoffmeister and Corinna Bliederhaeuser and Christoph Andreas Meier and Karine Madiona and Laura Pieri and Martin Kiechle and Pamela J. McLean and Jan Kassubek and Christian Behrends and Albert Christian Ludolph and Jochen Hans Weishaupt and Ronald Melki and Karin M. Danzer},
journal = {Annals of Neurology},
year = {2019},
doi = {10.1002/ana.25557},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2010
Open access · CC-BY
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Movement Disorders 2018
Open access · CC-BY
Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
Trends in Molecular Medicine 2012
Preprint · OA
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease
Acta Neuropathologica 2007
Citation only
α-Synuclein pathology in the neostriatum in Parkinson’s disease
JCI Insight 2021
Open access · CC-BY
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
Annals of Clinical and Translational Neurology 2014
Open access · CC-BY